Suppr超能文献

提供者对间质性肺疾病患者姑息治疗的看法及获取途径

Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.

作者信息

Gersten Rebecca A, Seth Bhavna, Arellano Luis, Shore Jessica, O'Hare Lanier, Patel Nina, Safdar Zeenat, Krishna Rachana, Mageto Yolanda, Cochran Darlene, Lindell Kathleen, Danoff Sonye K

机构信息

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD.

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD.

出版信息

Chest. 2022 Aug;162(2):375-384. doi: 10.1016/j.chest.2022.03.009. Epub 2022 Mar 17.

Abstract

BACKGROUND

Interstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning and symptom management in patients with ILD.

RESEARCH QUESTION

What are the current perspectives on PC among ILD providers, and what are the barriers to PC in ILD specialty centers?

STUDY DESIGN AND METHODS

A 24-question electronic survey was disseminated to providers at the 68 Pulmonary Fibrosis Foundation Care Centers across the United States from October 2020 to December 2020.

RESULTS

The survey was completed by 128 participants representing all 68 Pulmonary Fibrosis Foundation Care Center Network sites. Most respondents were physicians. Most providers exhibit good knowledge of, feel comfortable assessing a patient's readiness for, and agree with the need for PC for patients with ILD. Providers are most likely to refer to PC at objective disease and/or symptomatic progression rather than at initial diagnosis. In comparison with providers who report referring their patients to PC, providers who report rare referral are more likely to cite lack local PC availability (P < .01) and less likely to feel comfortable discussing prognosis/disease trajectory (P = .03) or feel it is important to address advance directives in ILD clinic (P = .02). There is a lack of standardized measures used to assess specific symptoms, overall symptom burden, or health-related quality of life across institutions. Discordance exists between self-reported and actual access to local inpatient and outpatient PC services.

INTERPRETATION

Most ILD providers use PC and are comfortable discussing PC. Barriers to PC identified in this survey include the following: perceived lack of local access to PC, lack of systematic tools to assess symptom burden, lack of established optimal timing of PC referral, and unclear need for specialized PC delivery.

摘要

背景

间质性肺疾病(ILD)会给患者带来严重的症状负担,并具有较高的死亡率。姑息治疗(PC)致力于改善重症患者的生活质量。早期提供姑息治疗可提高ILD患者的预立医疗计划和症状管理水平。

研究问题

ILD医疗服务提供者对姑息治疗的当前看法是什么,以及ILD专科中心提供姑息治疗的障碍有哪些?

研究设计与方法

2020年10月至2020年12月,向美国68个肺纤维化基金会护理中心的医疗服务提供者发放了一份包含24个问题的电子调查问卷。

结果

128名参与者完成了调查,他们代表了所有68个肺纤维化基金会护理中心网络站点。大多数受访者是医生。大多数医疗服务提供者对ILD患者的姑息治疗有良好的了解,对评估患者接受姑息治疗的意愿感到自在,并认同ILD患者需要姑息治疗。医疗服务提供者最有可能在客观疾病进展和/或出现症状时,而非在初始诊断时,将患者转介至姑息治疗。与报告将患者转介至姑息治疗的医疗服务提供者相比,报告很少转介的医疗服务提供者更有可能提到当地缺乏姑息治疗服务(P <.01),并且不太可能自在地讨论预后/疾病发展轨迹(P =.03),或者认为在ILD诊所处理预立医疗指示很重要(P =.02)。各机构之间缺乏用于评估特定症状、总体症状负担或健康相关生活质量的标准化措施。自我报告的当地住院和门诊姑息治疗服务获取情况与实际获取情况存在不一致。

解读

大多数ILD医疗服务提供者使用姑息治疗,并乐于讨论姑息治疗。本次调查中确定的姑息治疗障碍包括:认为当地难以获得姑息治疗服务、缺乏评估症状负担的系统工具、缺乏既定的最佳姑息治疗转介时机,以及对专门提供姑息治疗的需求不明确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4da/9633804/80666f26ce53/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验